Intellectual Property and Regulatory Law: Recent Developments | Parallel Trade 2018
Generic drug manufacturers can pose major financial threats to the companies that invent and develop the copied drugs both domestically and internationally. Even after a pharmaceutical company is granted patent protection on its products, there are other concerns about generics that Big Pharma face from abroad.
SMi’s 12th annual Parallel Trade conference, will return to Central London, 6th – 7th February 2018 to explore the relationship between parallel trader and the pharmaceutical industry. Already confirmed attendees include MHRA, Merck, Ferring Pharmaceuticals Ltd, Medac GmbH, Orifarm Generics, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Novartis and many more.
Intellectual property, consists largely of ideas and knowledge, it is a vital element of parallel trade. Arnold & Porter Kaye Scholer LLP’s, Patent Litigation & Strategy Partner, Christopher Stothers will take the stage at next year’s 12th annual Parallel Trade conference, in Central London, to address the evolving IPR strategy requiring a better focus and approach in the coming era, within the pharmaceutical industry. Christopher’s presentation will examine the following topics:
- IP developments in the EU and USA
- Regulatory issues
- Brexit focus: news and expectations
Christopher is a recognised expert in parallel trade, with a focus on the pharmaceutical sector – his 2007 textbook, “Parallel Trade in Europe: Intellectual Property, Competition and Regulatory Law,” has been cited by the UK Supreme Court. Christopher is also an experienced litigator on cross-border patent disputes, other types of intellectual property, antitrust, pharmaceutical regulation, EU law and commercial disputes. He has taken cases before the First Tier Tribunal, the Upper Tribunal, the Patents County Court, the High Court, the Court of Appeal, the House of Lords, the Supreme Court, the European Patent Office, and the European Court of Justice.
For more information about themust-attend meeting please visit: www.parallel-trade.com/PHARMAJOURNO
For those interested in registering, there is currently a £200 early bird discount available for all registrations made before 30th November.
For media enquiries please contact Kyra Williams on +44 20 7827 6012 or email kwilliams@smi-online.co.uk
For delegate enquiries contact Fateja Begum +44 (0) 207 827 6184or email fbegum@smi-online.co.uk
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
12th Annual Parallel Trade
6th – 7th February 2018
Holiday Inn Kensington, London, UK
www.parallel-trade.com/PHARMAJOURNO
#smiparalleltrade
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk